CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $648,000 | -27.6% | 142,800 | -8.4% | 0.00% | -100.0% |
| Q4 2020 | $895,000 | -22.2% | 155,965 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $1,150,000 | +115.0% | 158,865 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $535,000 | +274.1% | 153,365 | +59.1% | 0.00% | – |
| Q1 2020 | $143,000 | -24.3% | 96,400 | 0.0% | 0.00% | – |
| Q4 2019 | $189,000 | +80.0% | 96,400 | +368.0% | 0.00% | – |
| Q3 2019 | $105,000 | -25.0% | 20,600 | +5.0% | 0.00% | – |
| Q2 2019 | $140,000 | -61.3% | 19,618 | -57.4% | 0.00% | -100.0% |
| Q4 2018 | $362,000 | -40.0% | 46,028 | -15.4% | 0.00% | 0.0% |
| Q3 2018 | $603,000 | +25.1% | 54,420 | +46.7% | 0.00% | 0.0% |
| Q1 2018 | $482,000 | -1.0% | 37,096 | -29.9% | 0.00% | 0.0% |
| Q4 2017 | $487,000 | – | 52,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |